France has four public institutions in the world ranking of the most innovative structures. Inserm gains one place compared to the previous year.
And four for France! This is not a sporting result, but the number of public institutions hailed by the international ranking of the most innovative structures. Produced by Reuters and Clarivate, this ” Top 25 »Salutes the establishments whose scientific publications mark their field and which manage to publish patents. Published on March 1, it brings Inserm up one place compared to the previous year.
The National Institute of Health and Medical Research is thus listed in 9e position of this ranking. According to its CEO, Prof. Yves Lévy, this row “Once again demonstrates the very high quality of the Institute’s scientific production and strengthens Inserm’s position, with its subsidiary Inserm-Transfert, as a world leader in the healthcare innovation sector. “
The United States in the lead
The medical institution is not the only one to congratulate itself on its good results. The French Atomic Energy and Alternative Energies Commission (CEA) is also launching a large cocorico. Well justified, since the structure is classified 2e the most innovative establishment in the world. The CEA’s general administrator attributes this success to technological daring, including in fundamental research.
“The CEA fully expresses its ability to transform fundamental knowledge into concrete achievements, for the benefit of society and its economy”, Judge Daniel Verwaerde, in a communicated. The CNRS is also very well ranked since it is ahead of Inserm by one rank. Finally, the Institut Pasteur occupies the 15e position of this ranking. A desire for innovation that the Leem, a union representing drug manufacturers, had already recently welcomed.
Other big winners in this ranking are the United States and Germany, which each have five ranked institutions. American teams are rewarded for their research in multiple fields. Reuters thus emphasizes the involvement of the NIH (National Institutes of Health) in the development of CRISPR genome editing, and the preponderant role of the National Centers for Disease Control and Prevention (CDC) in the treatment of infectious diseases. , like malaria or Ebola.
.
